Literature DB >> 28826898

Relation of Chronic Obstructive Pulmonary Disease to Cardiovascular Disease in the General Population.

Shinjeong Song1, Pil-Sung Yang1, Tae-Hoon Kim1, Jae-Sun Uhm1, Hui-Nam Pak1, Moon-Hyoung Lee1, Boyoung Joung2.   

Abstract

Chronic obstructive pulmonary disease (COPD) is a major health problem that contributes to substantial morbidity and mortality globally. This study investigated the relation between COPD and the risk of cardiovascular disease in the general population. We evaluated the cardiovascular effect of COPD using Korean National Health Insurance Service data from 2002 to 2013. We compared selected cardiovascular disease risk factors depending on pulmonary function using the Korean Health and Nutritional Examination Survey (KNHANES, n = 24,429) data. COPD was diagnosed in 11,771 patients (2.4%) in the National Health Insurance Service cohort. During the follow-up period (45.5 ± 14.9 months), subjects with COPD had lower cumulative survival rate for all-cause mortality, cardiovascular mortality, and sudden cardiac death (SCD, all p values <0.001). COPD was associated with an increased risk of all-cause mortality even after adjustment for potential confounding variables (hazard ratio [HR] 1.43, 95% confidence interval [CI] 1.33 to 1.55, p <0.001). However, COPD did not significantly increase the risk of cardiovascular mortality (HR 1.02, 95% CI 0.84 to 1.22, p = 0.876) and SCD (HR 1.07, 95% CI 0.79 to 1.44, p = 0.664) when adjusted for potential confounding variables. Analysis of the KNHANES cohort showed that systolic blood pressure, current smoking status, and Framingham risk score increased progressively with a decrease in pulmonary function (all p <0.001). In conclusion, COPD was associated with all-cause mortality, but not with cardiovascular mortality and SCD, whereas poor pulmonary function was associated with a heightened cardiovascular risk.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 28826898     DOI: 10.1016/j.amjcard.2017.07.032

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  6 in total

1.  What Is the Ideal Blood Pressure Threshold for the Prevention of Atrial Fibrillation in Elderly General Population?

Authors:  Yoon Jung Park; Pil-Sung Yang; Hee Tae Yu; Tae-Hoon Kim; Eunsun Jang; Jae-Sun Uhm; Hui-Nam Pak; Moon-Hyoung Lee; Gregory Y H Lip; Boyoung Joung
Journal:  J Clin Med       Date:  2020-09-16       Impact factor: 4.241

2.  Comparison of risk profiles for new-onset atrial fibrillation between patients aged <60 and ≥60 years.

Authors:  In-Soo Kim; Yeon-Jik Choi; Eui-Young Choi; Pil-Ki Min; Young Won Yoon; Byoung Kwon Lee; Bum-Kee Hong; Se-Joong Rim; Hyuck Moon Kwon; Jong-Youn Kim
Journal:  PLoS One       Date:  2021-11-18       Impact factor: 3.752

3.  Variations of Prevalence and Incidence of Atrial Fibrillation and Oral Anticoagulation Rate According to Different Analysis Approaches.

Authors:  Pil-Sung Yang; Soorack Ryu; Daehoon Kim; Eunsun Jang; Hee Tae Yu; Tae-Hoon Kim; Jinseub Hwang; Boyoung Joung; Gregory Y H Lip
Journal:  Sci Rep       Date:  2018-05-01       Impact factor: 4.379

4.  The Summit Score Stratifies Mortality and Morbidity in Chronic Obstructive Pulmonary Disease.

Authors:  Benjamin D Horne; Matthew J Hegewald; Courtney Crim; Susan Rea; Tami L Bair; Denitza P Blagev
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2020-07-20

5.  Analysis of curative effect of adjuvant therapy with bronchoalveolar lavage on COPD patients complicated with pneumonia.

Authors:  Huan Zhao; Hongyan Gu; Tongmiao Liu; Juan Ge; Guanglin Shi
Journal:  Exp Ther Med       Date:  2018-08-29       Impact factor: 2.447

6.  Relative lymphocyte count as an indicator of 3-year mortality in elderly people with severe COPD.

Authors:  Domenico Acanfora; Pietro Scicchitano; Mauro Carone; Chiara Acanfora; Giuseppe Piscosquito; Roberto Maestri; Annapaola Zito; Ilaria Dentamaro; Marialaura Longobardi; Gerardo Casucci; Raffaele Antonelli-Incalzi; Marco Matteo Ciccone
Journal:  BMC Pulm Med       Date:  2018-07-13       Impact factor: 3.317

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.